{
    "clinical_study": {
        "@rank": "73754", 
        "arm_group": [
            {
                "arm_group_label": "Investigational", 
                "arm_group_type": "Experimental", 
                "description": "Subject receives Hem-Avert Device."
            }, 
            {
                "arm_group_label": "Control", 
                "arm_group_type": "No Intervention", 
                "description": "Subject does not receive Hem-Avert Device."
            }
        ], 
        "brief_summary": {
            "textblock": "A REDUCTION IN C-SECTION RATES USING THE HEM-AVERT\u00ae PERIANAL STABILIZER."
        }, 
        "brief_title": "A Reduction in C-section Rates Using the Hem-Avert Perianal Stabilizer", 
        "completion_date": {
            "#text": "January 2013", 
            "@type": "Actual"
        }, 
        "condition": "Complications; Cesarean Section", 
        "detailed_description": {
            "textblock": "This study is being conducted to evaluate an existing FDA approved device called the\n      HEM-AVERT\u00ae Perianal Stabilizer for its efficacy in reducing Cesarean births and/or reducing\n      the second stage of labor."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Subject is scheduled for vaginal delivery.\n\n          -  Subject is willing and able to comply with the study plan as indicated by\n             understanding and signing the Subject Informed Consent Form.\n\n          -  Subjects' pre-natal examination indicates that this is to be a single birth delivery.\n\n        Exclusion Criteria:\n\n          -  Subject's scheduled for vaginal delivery with anticipated complications.\n\n          -  Subject is unable to understand and sign the informed consent form.\n\n          -  Subject does not deliver at study facility (hospital)."
            }, 
            "gender": "Female", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "45 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "102", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "November 29, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01739543", 
            "org_study_id": "PB_002"
        }, 
        "intervention": {
            "arm_group_label": "Investigational", 
            "description": "Application of Hem-Avert", 
            "intervention_name": "Hem-Avert", 
            "intervention_type": "Device", 
            "other_name": "Hem-Avert Perianal Stabilizer"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "March 14, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Niagara Falls", 
                    "country": "United States", 
                    "state": "New York", 
                    "zip": "14301"
                }, 
                "name": "Niagara Falls Memorial Medical Center"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "A Reduction in C-section Rates Using the Hem-Avert Perianal Stabilizer", 
        "overall_official": {
            "affiliation": "Unafilliated", 
            "last_name": "Dan Burns, M.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "January 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "The primary objective (purpose) of this study is to evaluate the success rate of the HEM-AVERT\u00ae device as a method of reducing C-section rates", 
            "measure": "Reduce C-section Rate", 
            "safety_issue": "No", 
            "time_frame": "24 hours"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01739543"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "A secondary objective is to evaluate the success rate of the HEM-AVERT\u00ae device as a method of reducing the duration of second stage of labor", 
            "measure": "Reduce duration of 2nd stage of labor.", 
            "safety_issue": "No", 
            "time_frame": "24 hours"
        }, 
        "source": "Plexus Biomedical, Inc.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Plexus Biomedical, Inc.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "April 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "March 2013"
    }
}